In an attempt to predict the impact of the intronic LINC-ROR rs1942347A/T variant on cancer outcome, we ran the HaploReg v4.1; (https://pubs.broadinstitute.org/mammals/haploreg/haploreg.php) (last accessed 5 March 2022), a validated online bioinformatics tool specified for exploring annotations of the non-coding genome variants based on the 1000 Genomes Project, and on expression quantitative trait locus studies [43]. The gene discussed is LINC-ROR; the disease is cancer.